Crystal BioScience

Crystal Bioscience is a private company founded in 2008. Its platform relies on the large phylogenetic distance between mammals and birds to generate a variety of antibodies against human targets, which have proven difficult to address in mammals and other discoveries. Crystal Bioscience leverages unparalleled BioIntelligence™ and top-tier high-throughput screening technology to produce a vast array of target-specific antibodies, offering the highest quality therapeutic candidates for the broadest range of human diseases.